What PE Firms Get Wrong About EHR Data in Healthcare Due Diligence

Quick Answer

PE firms doing healthcare due diligence get the financials but miss the clinical data that explains whether those financials are durable. EHR data — specifically encounter volume by provider, referral network trends, coding distribution, and payer realization rates — surfaces provider concentration risk, referral fragility, and contract cliff exposure that a quality of earnings report cannot see. The practices with a data layer already built are materially easier to underwrite and to integrate post-close.

The standard healthcare due diligence package looks familiar: three years of financials, a quality of earnings report, payer mix by specialty, maybe a billing audit. It answers the question what has this practice earned?

What it rarely answers is why — and more importantly, is it durable?

That gap is where EHR data due diligence lives.

The Limitation of Financials Alone

Financial statements are a trailing indicator. By the time a revenue problem shows up in EBITDA, it has usually been building in the clinical data for six to eighteen months. Practices that look stable on paper can be sitting on a set of operational problems that will surface the quarter after close.

The issues that financials systematically miss:

Provider concentration risk. If 60% of revenue traces back to two physicians who are 58 and 61 years old, that's a succession problem. Financial statements show you the revenue. Only EHR data — specifically, encounter volume and RVU contribution by provider over time — shows you the concentration and the trend.

Referral network fragility. A practice's referring relationships often don't appear anywhere in a financial package. But inbound referral patterns are visible in the EHR, and a referral network that has been contracting for 18 months is a different asset than one that's been growing.

Payer contract cliff risk. Payer mix percentages in a financial package are static. EHR encounter data, joined to claims, shows you whether reimbursement rates on the same CPT codes have been drifting — which often signals an upcoming contract renegotiation that the seller hasn't flagged.

What a Proper EHR Diligence Pulls

In a typical pre-LOI or between-LOI-and-close engagement, we pull and analyze:

Encounter Volume and Provider Productivity

RVU production by provider, trended monthly over 36 months. We're looking for organic growth versus provider addition growth, seasonality patterns, and any individual provider whose volume has declined — which often precedes a departure.

Coding Distribution

How does each provider's E/M code distribution compare to specialty benchmarks? A practice billing at the 90th percentile for complexity has either exceptional documentation discipline or a compliance exposure. Knowing which one matters before you close.

Diagnosis and Procedure Mix

Case mix drives reimbursement, and reimbursement drives the underlying economics. We look for shifts in procedure mix that haven't yet flowed through to the financial statements — both opportunities (a high-margin procedure line that's underutilized) and risks (a declining procedure line that represents a meaningful revenue concentration).

Referral Network Analysis

Who is sending patients, how has that changed over three years, and how geographically diverse is the inbound network? A practice dependent on two large health system referral relationships is exposed in a way that doesn't show up in the P&L.

Payor Realization Rates

The same CPT code billed to the same payer should reimburse consistently. When it doesn't, something is wrong — either with the billing, the contract, or how the practice is coding. Variance in realized rates by payer over time is one of the cleanest signals of operational quality we've found.

The Data Access Problem

The limiting factor in EHR due diligence is almost always data access, not analytical capability. Sellers are (understandably) reluctant to grant API access to operational systems during diligence. The practical approach is a combination of:

• De-identified data extracts for encounter and claim-level analysis
• Report pulls from the EHR's built-in analytics module (every major platform has one)
• Billing system exports that can be joined to EHR data with common encounter IDs

Getting clean, joinable data out of an acquired practice is a known problem. The practices that have already built a data layer — even a basic one — are meaningfully easier to integrate post-close and command a premium in the diligence process for it.

What Changes After Close

The EHR data analysis done during diligence shouldn't stop at close. The same metrics used to underwrite the deal become the foundation of the 100-day operational plan:

• Provider productivity targets grounded in pre-close benchmarks
• Referral network development priorities based on where the gaps are
• Coding education for providers whose E/M distribution is outlier-low (leaving revenue on the table) or outlier-high (compliance risk)

Diligence data and operational data should live in the same model. That continuity — from underwriting through operations — is what separates a healthcare PE firm that compounds well from one that perpetually underwrites the same surprises.

Key Takeaways

• Financials are a trailing indicator: revenue problems build in clinical data 6–18 months before appearing in EBITDA — EHR diligence closes that gap.
• Provider concentration is the most common hidden risk: RVU production by provider over 36 months reveals whether growth is organic or dependent on one or two physicians nearing retirement.
• Referral network trends don't appear in a P&L: only EHR encounter data shows whether the inbound referral network has been growing or contracting — and who is exposed if a key referring relationship ends.
• Coding distribution is both a revenue and compliance signal: outlier E/M billing relative to specialty benchmarks may indicate captured revenue opportunity or a pre-close compliance exposure that a payer will eventually audit.
• Diligence data should become operational data: the metrics used to underwrite the deal are the same ones that drive the 100-day plan — practices with a data layer already in place close faster and integrate more cleanly.